Soluble urokinase plasminogen activator receptor (suPAR) levels predict damage accrual in patients with recent-onset systemic lupus erythematosus
Helena Enocsson, Lina Wirestam, Charlotte Dahle, Leonid Padyukov, Andreas Jönsen, Murray B Urowitz, Dafna D Gladman, Juanita Romero-Diaz, Sang-Cheol Bae, Paul R Fortin, Jorge Sanchez-Guerrero, Ann E Clarke, Sasha Bernatsky, Caroline Gordon, John G Hanly, Daniel J Wallace, David A Isenberg, Anisur Rahman, Joan T Merrill, Ellen GinzlerGraciela S Alarcón, W Winn Chatham, Michelle Petri, Munther Khamashta, Cynthia Aranow, Meggan Mackay, Mary Anne Dooley, Susan Manzi, Rosalind Ramsey-Goldman, Ola Nived, Kristjan Steinsson, Asad A Zoma, Guillermo Ruiz-Irastorza, S Sam Lim, Kenneth C Kalunian, Murat Inanc, Ronald F van Vollenhoven, Manuel Ramos-Casals, Diane L Kamen, Søren Jacobsen, Christine A Peschken, Anca Askanase, Thomas Stoll, Ian N Bruce, Jonas Wetterö, Christopher Sjöwall
Dive into the research topics of 'Soluble urokinase plasminogen activator receptor (suPAR) levels predict damage accrual in patients with recent-onset systemic lupus erythematosus'. Together they form a unique fingerprint.